Navitor Pharmaceuticals, Inc.
4 clinical trials · Sponsor
◉ Watch Navitor Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Open-Label of SPN-820 in Adults With Major Depressive Disorder (NCT06235905) | Navitor Pharmaceuticals, Inc. | 2024-02-15 |
| Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression (NCT05066672) | Navitor Pharmaceuticals, Inc. | 2022-01-18 |
| Mass Balance Study of NV-5138 in Healthy Male Subjects. (NCT05152680) | Navitor Pharmaceuticals, Inc. | 2021-11-11 |
| Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression (NCT03606395) | Navitor Pharmaceuticals, Inc. | 2018-06-06 |
Track Navitor Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.